Global Sepsis Diagnostics Market Report

Global Sepsis Diagnostics Market, By Technology (Molecular Diagnostics, Microbiology, Immunoassay, and Other Technologies), By Product (Instruments, Assays and Reagents, Blood Culture Media, and Other Products), By Pathogen (Bacterial Sepsis, Fungal Sepsis, and Other Pathogens), By Region (North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle-East & Africa (MEA) Trend Analysis, Competitive Market Share & Forecast, 2017-2027

  • Published Date: July 2021
  • Report ID: BWC21403
  • Available Format: PDF
  • Page: 141

1. Research Framework

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.    Research Methodology

2.1. Qualitative Research

2.1.1.   Primary and Secondary Sources

2.2. Quantitative Research

2.2.1.   Primary and Secondary Sources

2.3. Breakdown of Primary Research Respondents

2.3.1.   Secondary Research

2.3.2.   Primary Research

2.4. Breakdown of Primary Research Respondents, By Industry Participants

2.5. Key Questionnaire asked during Primary Interviews

2.6. Key Primary Responses

2.7. Market Size Estimation

2.8. Assumption for the Study

2.9. Market Breakdown & Data Triangulation

3.    Executive Summary

4.    Global Sepsis Diagnostics Market – Industry Insights

4.1. DROC Analysis

4.1.1.   Growth Drivers

4.1.2.   Restraints

4.1.3.   Opportunity

4.1.4.   Challenges

4.2. Recent Developments / Technical Landscape

4.3. Regulatory Framework

4.4. Porter’s Five Forces Analysis

4.5. Value Chain Analysis

4.6. Strategic Outlook

5.    Global Sepsis Diagnostics Market Overview

5.1. Market Estimates & Forecast by Value, 2017-2027

5.1.1.   By Value (USD Million)

5.2. Market Share & Forecast

5.2.1.   By Technology

5.2.1.1. Molecular Diagnostics

5.2.1.2. Microbiology

5.2.1.3. Immunoassay

5.2.1.4. Other Technologies

5.2.2.   By Product

5.2.2.1. Instruments

5.2.2.2. Assays And Reagents

5.2.2.3. Blood Culture Media

5.2.2.4. Other Products

5.2.3.   By Pathogen

5.2.3.1. Bacterial Sepsis

5.2.3.1.1.      Gram-Negative Bacterial Sepsis

5.2.3.1.2.      Gram-Positive Bacterial Sepsis

5.2.3.2. Fungal Sepsis

5.2.3.3. Other Pathogens

5.2.4.   By Region

5.2.4.1. North America

5.2.4.2. Europe

5.2.4.3. Asia-Pacific (APAC)

5.2.4.4. Latin America (LATAM)

5.2.4.5. Middle-East & Africa (MEA)

6.    North America Sepsis Diagnostics Market Overview

6.1. Market Size and Forecast

6.1.1.   By Value (USD Million), 2017-2027

6.2. Market Share and Forecast

6.2.1.   By Technology

6.2.2.   By Product

6.2.3.   By Pathogen

6.2.4.   By Country

6.2.4.1. U.S.

6.2.4.2. Canada

7.    Europe Sepsis Diagnostics Market Overview

7.1.     Market Size and Forecast

7.1.1.   By Value (USD Million), 2017-2027

7.2.     Market Share and Forecast

7.2.1.   By Technology

7.2.2.   By Product

7.2.3.   By Pathogen

7.2.4.   By Country

7.2.4.1.   Germany

7.2.4.2.   U.K.

7.2.4.3.   France

7.2.4.4.   Italy

7.2.4.5.   Spain

7.2.4.6.   Russia

7.2.4.7.   Netherlands

7.2.4.8.   Rest of Europe

8.    APAC Sepsis Diagnostics Market Overview

8.1.     Market Size and Forecast

8.1.1.   By Value (USD Million), 2017-2027

8.2.     Market Share and Forecast

8.2.1.   By Technology

8.2.2.   By Product

8.2.3.   By Pathogen

8.2.4.   By Country

8.2.4.1.   China

8.2.4.2.   India

8.2.4.3.   Japan

8.2.4.4.   South Korea

8.2.4.5.   Rest of APAC

9.    LATAM Sepsis Diagnostics Market Overview

9.1.     Market Size and Forecast

9.1.1.   By Value (USD Million), 2017-2027

9.2.     Market Share and Forecast

9.2.1.   By Technology

9.2.2.   By Product

9.2.3.   By Pathogen

9.2.4.   By Country

9.2.4.1.   Mexico

9.2.4.2.   Brazil

9.2.4.3.   Rest of LATAM

10.MEA Sepsis Diagnostics Market Overview

10.1.   Market Size and Forecast

10.1.1.                By Value (USD Million), 2017-2027

10.2.   Market Share and Forecast

10.2.1.                By Technology

10.2.2.                By Product

10.2.3.                By Pathogen

10.2.4.                By Country

10.2.4.1.              Saudi Arabia

10.2.4.2.              UAE

10.2.4.3.              South Africa

10.2.4.4.              Turkey

10.2.4.5.              Rest of Europe

11.Competitive Landscape

11.1.1.                List of Key Players and Their Offerings

11.1.2.                Market Share / Ranking Analysis (2020)

11.1.3.                Competitive Benchmarking, By Operating Parameters

12.COVID-19 Impact

12.1.             Future Impact

12.2.             Key Developments during COVID-19

12.3.             Impact on Market

12.3.1.                Different Scenario

12.3.2.                Impact on Companies

12.4.             Regional Impact

13.Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *

13.1.             Danaher Corporation

13.2.             Cube Dx GmbH

13.3.             Beckman Coulter, Inc

13.4.             Abbott Laboratories Inc.

13.5.             Immunexpress Inc.

13.6.             Response Biomedical Corp.

13.7.             Axis-Shield Diagnostics Ltd.

13.8.             Beckman Coulter, Inc

13.9.             Nanosphere, Inc.

13.10.          Sysmex Corporation

13.11.          T2 Biosystems, Inc.

13.12.          F. Hoffmann-LA Roche Ltd

13.13.          BioMerieux SA

13.14.          Bruker Corporation

13.15.          EKF Diagnostics

13.16.          Thermo Fisher Scientific

13.17.          T2 Biosystems, Inc.

13.18.          Cytosorbents

13.19.          Genmark Diagnostics

13.20.        Other Prominent Players

14.Key Strategic Recommendations

 

* Financial information of non-listed Companies will be provided as per availability

 

**The segmentation and the companies are subjected to modifications based on in-depth study during the final deliverable.

 

 

List of Figures

 

Fig: Global Sepsis Diagnostics Segmentation

 

Fig: Global Sepsis Diagnostics Market Value Chain Analysis,

 

Fig: Company Market Share Analysis, 2020

 

Fig: Global Sepsis Diagnostics Market Size, By Value (USD Million), 2017-2027

 

Fig: Global Sepsis Diagnostics Market Share (%), By Technology, By Value, 2017-2027

 

Fig: Global Sepsis Diagnostics Market Share (%), By Product, By Value, 2017-2027

 

Fig: Global Sepsis Diagnostics Market Share (%), By Pathogen, By Value, 2017-2027

 

Fig: Global Sepsis Diagnostics Market Share (%), By Country, By Value, 2017-2027

 

Fig: North America Sepsis Diagnostics Market Size, By Value (USD Million), 2017-2027

 

Fig: North America Sepsis Diagnostics Market Share (%), By Technology, By Value, 2017-2027

 

Fig: North America Sepsis Diagnostics Market Share (%), By Product, By Value, 2017-2027

 

Fig: North America Sepsis Diagnostics Market Share (%), By Pathogen, By Value, 2017-2027

 

Fig: North America Sepsis Diagnostics Market Share (%), By Country, By Value, 2017-2027

 

Fig: Europe Sepsis Diagnostics Market Size, By Value (USD Million), 2017-2027

 

Fig: Europe Sepsis Diagnostics Market Share (%), By Technology, By Value, 2017-2027

 

Fig: Europe Sepsis Diagnostics Market Share (%), By Product, By Value, 2017-2027

 

Fig: Europe Sepsis Diagnostics Market Share (%), By Pathogen, By Value, 2017-2027

 

Fig: Europe Sepsis Diagnostics Market Share (%), By Country, By Value, 2017-2027

 

Fig: the Asia-Pacific Sepsis Diagnostics Market Size, By Value (USD Million), 2017-2027

 

Fig: the Asia-Pacific Sepsis Diagnostics Market Share (%), By Technology, By Value, 2017-2027

 

Fig: the Asia-Pacific Sepsis Diagnostics Market Share (%), By Product, By Value, 2017-2027

 

Fig: the Asia-Pacific Sepsis Diagnostics Market Share (%), By Pathogen, By Value, 2017-2027

 

Fig: the Asia-Pacific Sepsis Diagnostics Market Share (%), By Country, By Value, 2017-2027

 

Fig: Latin America Sepsis Diagnostics Market Size, By Value (USD Million), 2017-2027

 

Fig: Latin America Sepsis Diagnostics Market Share (%), By Technology, By Value, 2017-2027

 

Fig: Latin America Sepsis Diagnostics Market Share (%), By Product, By Value, 2017-2027

Fig: Latin America Sepsis Diagnostics Market Share (%), By Pathogen, By Value, 2017-2027

 

Fig: Latin America Sepsis Diagnostics Market Share (%), By Country, By Value, 2017-2027

 

Fig: Middle East & Africa Sepsis Diagnostics Market Size, By Value (USD Million), 2017-2027

 

Fig: Middle East & Africa Sepsis Diagnostics Market Share (%), By Technology, By Value, 2017-2027

 

Fig: Middle East & Africa Sepsis Diagnostics Market Share (%), By Product, By Value, 2017-2027

 

Fig: Middle East & Africa Sepsis Diagnostics Market Share (%), By Pathogen, By Value, 2017-2027

 

Fig: Middle East & Africa Sepsis Diagnostics Market Share (%), By Region, By Value, 2017-2027

 

 

List of Tables

 

Table: Global Container Glass Market Size, By Region, By Value, 2017-2027

 

Table: North America Sepsis Diagnostics Market Size, By Technology, By Value (USD Million), 2017-2027

 

Table: North America Sepsis Diagnostics Market Size, By Product, By Value (USD Million), 2017-2027

 

Table: North America Sepsis Diagnostics Market Size, By Pathogen, By Value (USD Million), 2017-2027

 

Table: Europe Sepsis Diagnostics Market Size, By Technology, By Value (USD Million), 2017-2027

 

Table: Europe Sepsis Diagnostics Market Size, By Product, By Value (USD Million), 2017-2027

 

Table: Europe Sepsis Diagnostics Market Size, By Pathogen, By Value (USD Million), 2017-2027

 

Table: the Asia-Pacific Sepsis Diagnostics Market Size, By Technology, By Value (USD Million), 2017-2027

 

Table: the Asia-Pacific Sepsis Diagnostics Market Size, By Product, By Value (USD Million), 2017-2027

 

Table: the Asia-Pacific Sepsis Diagnostics Market Size, By Pathogen, By Value (USD Million), 2017-2027

 

Table: Latin America Sepsis Diagnostics Market Size, By Technology, By Value (USD Million), 2017-2027

 

Table: Latin America Sepsis Diagnostics Market Size, By Product, By Value (USD Million), 2017-2027

 

Table: Latin America Sepsis Diagnostics Market Size, By Pathogen, By Value (USD Million), 2017-2027

 

Table: The Middle-East & Africa Sepsis Diagnostics Market Size, By Technology, By Value (USD Million), 2017-2027

 

Table: The Middle-East & Africa Sepsis Diagnostics Market Size, By Product, By Value (USD Million), 2017-2027

 

Table: The Middle-East & Africa Sepsis Diagnostics Market Size, By Pathogen, By Value (USD Million), 2017-2027

 

Table: Danaher Corporation Financial Analysis

Table: Danaher Corporation Business Overview

Table: Cube Dx GmbH Financial Analysis

Table: Cube Dx GmbH Business Overview

Table: Beckman Coulter, Inc. Financial Analysis

 Table: Beckman Coulter, Inc. Business Overview

Table: Abbott Laboratories Inc. Financial Analysis

Table: Abbott Laboratories Inc. Business Overview

Table: Immunexpress Inc. Financial Analysis

Table: Immunexpress Inc. Business Overview

Table: Response Biomedical Corp. Financial Analysis

Table: Response Biomedical Corp. Business Overview

Table: Axis-Shield Diagnostics Ltd. Financial Analysis

Table: Axis-Shield Diagnostics Ltd. Business Overview

Table: Beckman Coulter, Inc Financial Analysis

Table: Beckman Coulter, Inc Business Overview

Table: Nanosphere, Inc. Financial Analysis

Table: Nanosphere, Inc. Business Overview

Table: Sysmex Corporation Financial Analysis

Table: Sysmex Corporation Business Overview

Table: T2 Biosystems, Inc. Financial Analysis

Table: T2 Biosystems, Inc. Financial Analysis

Table: F. Hoffmann-LA Roche Ltd Financial Analysis

Table: F. Hoffmann-LA Roche Ltd Glass Business Overview

Table: BioMerieux SA Financial Analysis

Table: BioMerieux SA Glass Business Overview

Table: Bruker Corporation Financial Analysis

Table: Bruker Corporation Glass Business Overview

Table: EKF Diagnostics Financial Analysis

Table: EKF Diagnostics Glass Business Overview

Table: Thermo Fisher Scientific Financial Analysis

Table: Thermo Fisher Scientific Glass Business Overview

Table: T2 Biosystems, Inc. Financial Analysis

Table: T2 Biosystems, Inc. Glass Business Overview

Table: Cytosorbents Financial Analysis

Table: Cytosorbents Glass Business Overview

Table: Genmark Diagnostics Financial Analysis

 

Table: Genmark Diagnostics Glass Business Overview